Investigating the Role of Lipid Transfer in Microbubble-Mediated Drug Delivery

Sonoporation, the permeabilization of cell membranes following exposure to microbubbles and ultrasound, has considerable potential for therapeutic delivery. To date, engineering of microbubbles for these applications has focused primarily upon optimizing microbubble size and stability, or attachment...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 35(2019), 40 vom: 08. Okt., Seite 13205-13215
1. Verfasser: Aron, Miles (VerfasserIn)
Weitere Verfasser: Vince, Oliver, Gray, Michael, Mannaris, Christophoros, Stride, Eleanor
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Drug Carriers Phosphatidylcholines
LEADER 01000naa a22002652 4500
001 NLM301260184
003 DE-627
005 20231225104246.0
007 cr uuu---uuuuu
008 231225s2019 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.langmuir.9b02404  |2 doi 
028 5 2 |a pubmed24n1004.xml 
035 |a (DE-627)NLM301260184 
035 |a (NLM)31517490 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Aron, Miles  |e verfasserin  |4 aut 
245 1 0 |a Investigating the Role of Lipid Transfer in Microbubble-Mediated Drug Delivery 
264 1 |c 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 21.09.2020 
500 |a Date Revised 21.09.2020 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Sonoporation, the permeabilization of cell membranes following exposure to microbubbles and ultrasound, has considerable potential for therapeutic delivery. To date, engineering of microbubbles for these applications has focused primarily upon optimizing microbubble size and stability, or attachment of targeting species and/or drug molecules. In this work, it is demonstrated that the microbubble coating can also be tailored to directly influence cell permeabilization. Specifically, lipid exchange mechanisms between phospholipid microbubbles and cells can be exploited to significantly increase sonoporation efficiency in vitro. A theoretical analysis of the energy required for pore formation was carried out. From this, it was hypothesized that sonoporation could be promoted by the transfer of lipid molecules with appropriate carbon chain length and/or shape (cylindrical or conical). Spectral imaging with a hydration-sensitive membrane probe (C-Laurdan) was used to measure changes in the membrane lipid order of A-549 cancer cells following exposure to suspensions of different phospholipids. Two candidate lipids were identified, a short-chain-length phospholipid (1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC)) and a medium-chain-length lysolipid (1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (16:0 lyso-PC)). Microbubbles were prepared with matched concentrations, size distributions, and acoustic responses. Confocal microscopy was used to measure cell uptake of a model drug (propidium iodide) with and without ultrasound exposure (1 MHz, 250 kPa peak negative pressure, 1 kHz pulse repetition frequency, 10% duty cycle, 15 s exposure). Despite significantly decreasing the cell membrane lipid order, DLPC did not increase sonoporation. Microbubbles containing 16:0 lyso-PC, however, produced a ∼5-fold increase in sonoporation compared to control microbubbles. Importantly, the lyso-PC molecules were incorporated into the microbubble coating and did not affect cell permeability prior to ultrasound exposure. These findings indicate that microbubbles can be engineered to exploit lipid exchange between microbubble shells and cell membranes to enhance drug delivery, a new optimization route that may lead to enhanced therapeutic efficacy of ultrasound-mediated treatments 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Drug Carriers  |2 NLM 
650 7 |a Phosphatidylcholines  |2 NLM 
700 1 |a Vince, Oliver  |e verfasserin  |4 aut 
700 1 |a Gray, Michael  |e verfasserin  |4 aut 
700 1 |a Mannaris, Christophoros  |e verfasserin  |4 aut 
700 1 |a Stride, Eleanor  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1992  |g 35(2019), 40 vom: 08. Okt., Seite 13205-13215  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:35  |g year:2019  |g number:40  |g day:08  |g month:10  |g pages:13205-13215 
856 4 0 |u http://dx.doi.org/10.1021/acs.langmuir.9b02404  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 35  |j 2019  |e 40  |b 08  |c 10  |h 13205-13215